Cancer Research Meeting Calendar  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bishop, A. J. R.
Right arrow Articles by Schiestl, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bishop, A. J. R.
Right arrow Articles by Schiestl, R. H.
[Cancer Research 60, 395-399, January 15, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

Atm Deficiency Causes an Increased Frequency of Intrachromosomal Homologous Recombination in Mice1

Alexander J. R. Bishop, Carrolee Barlow, Anthony J. Wynshaw-Boris and Robert H. Schiestl2

Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115 [A. J. R. B., R. H. S]; Genetic Disease Research Branch, National Genome Research Institute, NIH, Bethesda, Maryland 20892 [C. B., A. J. W-B.]; The Salk Institute for Biological Studies, La Jolla, California 92037 [C. B.]; and University of California, San Diego School of Medicine, La Jolla, California 92093 [A. J. W-B.]

Ataxia telangiectasia (AT) patients have inactivating mutations in both copies of the ATM gene. The ATM protein that the gene encodes is involved in DNA double-strand break (DSB) recognition; in its absence, p53 response to DSBs is delayed and reduced. In addition, AT patients have a high propensity for cancer, and cells from these patients show chromosomal instability. Here, using an in vivo mouse model system with the pink-eyed unstable mutation, we demonstrate that the absence of functional Atm results in a significantly elevated frequency of intrachromosomal recombination resulting in deletion events (wild-type 17.73%, heterozygous Atm 15.72%, and mutant Atm 30.33%). No such increase was observed in mice heterozygous for Atm. These results further advocate the role of ATM in maintaining genomic integrity after the onset of endogenous damage. This system relies on the initiation of events during a relatively short time frame to produce an observable deletion product. AT patients have a lifelong exposure to endogenous damage and perhaps similarly acting external agents. Because 25% of our genome consists of repeated elements, genomic instability due to an increased level of homologous recombination between such repeats, as observed here, may contribute to carcinogenesis in AT patients.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Mierau, G. A. Drexler, A. Kutzera, K. Braunschmidt, J. Ellwart, F. Eckardt-Schupp, E. Fritz, J. Bachl, and B. Jungnickel
Non-conservative homologous recombination in human B lymphocytes is promoted by activation-induced cytidine deaminase and transcription
Nucleic Acids Res., October 1, 2008; 36(17): 5591 - 5601.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. K. Ahuja, R. C. Barber, R. J. Hardwick, M. M. Weil, P. C. Genik, D. J. Brenner, and Y. E. Dubrova
The effects of Atm haploinsufficiency on mutation rate in the mouse germ line and somatic tissue
Mutagenesis, September 1, 2008; 23(5): 367 - 370.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. A. Gatz, M. Keimling, C. Baumann, T. Dork, K.-M. Debatin, S. Fulda, and L. Wiesmuller
Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and -Nbs1-dependent manner
Carcinogenesis, March 1, 2008; 29(3): 519 - 527.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. R. LaRocque, D. L. Dougherty, S. K. Hussain, and J. Sekelsky
Reducing DNA Polymerase {alpha} in the Absence of Drosophila ATR Leads to P53-Dependent Apoptosis and Developmental Defects
Genetics, July 1, 2007; 176(3): 1441 - 1451.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Kirpnick-Sobol, R. Reliene, and R. H. Schiestl
Carcinogenic Cr(VI) and the Nutritional Supplement Cr(III) Induce DNA Deletions in Yeast and Mice.
Cancer Res., April 1, 2006; 66(7): 3480 - 3484.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Reliene and R. H. Schiestl
Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice
Carcinogenesis, February 1, 2006; 27(2): 240 - 244.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. J. Winrow, D. G. Pankratz, C. R. T. Vibat, T.J. Bowen, M. A. Callahan, A. J. Warren, B. S. Hilbush, A. Wynshaw-Boris, K. W. Hasel, Z. Weaver, et al.
Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas
Hum. Mol. Genet., September 15, 2005; 14(18): 2671 - 2684.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
O. Kovalchuk, C. A. Hendricks, S. Cassie, A. J. Engelward, and B. P. Engelward
In vivo Recombination After Chronic Damage Exposure Falls to Below Spontaneous Levels in "Recombomice"
Mol. Cancer Res., October 1, 2004; 2(10): 567 - 573.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Reliene, E. Fischer, and R. H. Schiestl
Effect of N-Acetyl Cysteine on Oxidative DNA Damage and the Frequency of DNA Deletions in Atm-Deficient Mice
Cancer Res., August 1, 2004; 64(15): 5148 - 5153.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Hirt, F. Schuler, L. Dolken, C. A. Schmidt, and G. Dolken
Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR
Blood, August 1, 2004; 104(3): 904 - 905.
[Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. R. Bishop, M. C. Hollander, B. Kosaras, R. L. Sidman, A. J. Fornace Jr., and R. H. Schiestl
Atm-, p53-, and Gadd45a-Deficient Mice Show an Increased Frequency of Homologous Recombination at Different Stages during Development
Cancer Res., September 1, 2003; 63(17): 5335 - 5343.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. Hendricks, K. H. Almeida, M. S. Stitt, V. S. Jonnalagadda, R. E. Rugo, G. F. Kerrison, and B. P. Engelward
Spontaneous mitotic homologous recombination at an enhanced yellow fluorescent protein (EYFP) cDNA direct repeat in transgenic mice
PNAS, May 27, 2003; 100(11): 6325 - 6330.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Zentilin, A. Marcello, and M. Giacca
Involvement of Cellular Double-Stranded DNA Break Binding Proteins in Processing of the Recombinant Adeno-Associated Virus Genome
J. Virol., December 15, 2001; 75(24): 12279 - 12287.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. R. Anderson, B. M. Brenner, H. Swede, N. Chen, W. M. Henry, J. M. Conroy, M. J. Karpenko, J.-P. Issa, J. D. Bartos, J. K. Brunelle, et al.
Intrachromosomal Genomic Instability in Human Sporadic Colorectal Cancer Measured by Genome-Wide Allelotyping and Inter-(Simple Sequence Repeat) PCR
Cancer Res., November 1, 2001; 61(22): 8274 - 8283.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Vasquez, K. Marburger, Z. Intody, and J. H. Wilson
Manipulating the mammalian genome by homologous recombination
PNAS, July 17, 2001; 98(15): 8403 - 8410.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A.J.R. Bishop, B. Kosaras, N. Carls, R.L. Sidman, and R.H. Schiestl
Susceptibility of proliferating cells to benzo[a]pyrene-induced homologous recombination in mice
Carcinogenesis, April 1, 2001; 22(4): 641 - 649.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M.-d. Murcia, M. Mark, O. Wendling, A. Wynshaw-Boris, and G. de Murcia
Early Embryonic Lethality in PARP-1 Atm Double-Mutant Mice Suggests a Functional Synergy in Cell Proliferation during Development
Mol. Cell. Biol., March 1, 2001; 21(5): 1828 - 1832.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
N. Welzel, T. Le, R. Marculescu, G. Mitterbauer, A. Chott, C. Pott, M. Kneba, M.-Q. Du, R. Kusec, J. Drach, et al.
Templated Nucleotide Addition and Immunoglobulin JH-Gene Utilization in t(11;14) Junctions: Implications for the Mechanism of Translocation and the Origin of Mantle Cell Lymphoma
Cancer Res., February 1, 2001; 61(4): 1629 - 1636.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
J. E. French, G. D. Lacks, C. Trempus, J. K. Dunnick, J. Foley, J. Mahler, R. R. Tice, and R. W. Tennant
Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent
Carcinogenesis, January 1, 2001; 22(1): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. J.R. Bishop and R. H. Schiestl
Homologous recombination as a mechanism for genome rearrangements: environmental and genetic effects
Hum. Mol. Genet., October 1, 2000; 9(16): 2427 - 2334.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.